Third GPCR-Targeted Drug Enters Clinic under Sosei/Pfizer Collaboration

Sosei Group said on May 19 that the third G protein-coupled receptor (GPCR)-targeted oral small molecule compound has entered the clinic under its multi-target drug discovery collaboration with Pfizer, triggering a milestone payment of US$5 million from the US giant...read more